X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE FULFORD INDIA TTK HEALTHCARE/
FULFORD INDIA
 
P/E (TTM) x 22.0 398.8 5.5% View Chart
P/BV x 7.4 6.2 119.3% View Chart
Dividend Yield % 0.4 0.1 462.8%  

Financials

 TTK HEALTHCARE   FULFORD INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
FULFORD INDIA
Mar-14
TTK HEALTHCARE/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs663942 70.4%   
Low Rs399450 88.7%   
Sales per share (Unadj.) Rs535.6691.4 77.5%  
Earnings per share (Unadj.) Rs15.911.5 139.1%  
Cash flow per share (Unadj.) Rs20.015.4 130.4%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.3 262.0%  
Book value per share (Unadj.) Rs137.6380.0 36.2%  
Shares outstanding (eoy) m7.773.90 199.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.0 98.5%   
Avg P/E ratio x33.360.7 54.9%  
P/CF ratio (eoy) x26.545.3 58.5%  
Price / Book Value ratio x3.91.8 210.7%  
Dividend payout %25.117.4 143.8%   
Avg Mkt Cap Rs m4,1272,714 152.1%   
No. of employees `0001.70.4 384.7%   
Total wages/salary Rs m607505 120.1%   
Avg. sales/employee Rs Th2,436.76,073.0 40.1%   
Avg. wages/employee Rs Th355.21,137.4 31.2%   
Avg. net profit/employee Rs Th72.5100.7 72.1%   
INCOME DATA
Net Sales Rs m4,1622,696 154.3%  
Other income Rs m61125 48.8%   
Total revenues Rs m4,2232,822 149.7%   
Gross profit Rs m197-46 -424.8%  
Depreciation Rs m3215 208.6%   
Interest Rs m3010 314.7%   
Profit before tax Rs m19754 362.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7310 758.3%   
Profit after tax Rs m12445 277.2%  
Gross profit margin %4.7-1.7 -275.2%  
Effective tax rate %37.017.7 209.3%   
Net profit margin %3.01.7 179.6%  
BALANCE SHEET DATA
Current assets Rs m1,6291,738 93.7%   
Current liabilities Rs m1,058545 194.2%   
Net working cap to sales %13.744.3 31.0%  
Current ratio x1.53.2 48.2%  
Inventory Days Days3048 61.4%  
Debtors Days Days344 780.3%  
Net fixed assets Rs m55612 4,674.8%   
Share capital Rs m7839 199.2%   
"Free" reserves Rs m8781,443 60.9%   
Net worth Rs m1,0691,482 72.2%   
Long term debt Rs m1590-   
Total assets Rs m2,3992,077 115.5%  
Interest coverage x7.66.7 112.8%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.71.3 133.6%   
Return on assets %6.42.6 245.6%  
Return on equity %11.63.0 384.2%  
Return on capital %18.54.3 428.6%  
Exports to sales %0.80-   
Imports to sales %1.424.5 5.7%   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58659 8.8%   
Fx inflow Rs m3317 191.3%   
Fx outflow Rs m63673 9.4%   
Net fx Rs m-30-656 4.6%   
CASH FLOW
From Operations Rs m12790 140.7%  
From Investments Rs m-146105 -139.6%  
From Financial Activity Rs m22-14 -155.3%  
Net Cashflow Rs m3181 1.4%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 3.8 97.4%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.2 121.7%  
Shareholders   12,723 4,783 266.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 17, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS